Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02781883
Title Clinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With LDAC in Patients With Previously Untreated AML
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bio-Path Holdings, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Medical Center RECRUITING Los Angeles California 90095 United States Details
Georgia Cancer Center at Augusta University RECRUITING Augusta Georgia 30912 United States Details
University of Kansas Cancer Center RECRUITING Fairway Kansas 66205 United States Details
New Jersey Hematology Oncology Associates TERMINATED Brick New Jersey 08724 United States Details
Laura & Isaac Pe lmutter Cancer Center at NYU Langone Health RECRUITING New York New York 10016 United States Details
Weill Cornell Medical College - New York - Presbyterian Hospital RECRUITING New York New York 10021 United States Details
University of Texas M.D. Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Baylor Scott & White Research Institute TERMINATED Temple Texas 76508 United States Details
West Virginia University/Mary Babb Randolph Cancer Center TERMINATED Morgantown West Virginia 26506 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field